- Country: Russia
- Summary: the Drug Isosorbide Monononitrate, Soliphenacin, Potassium Iodide, Ambroxol for Medical Use by Prescription for Drugs to Ensure about ...
- RUT Ref No: 127632889
- Deadline: 10 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 215846.40
- Notice Type: Tender
- Document Ref. No.: 0168200001225000207
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The drug isosorbida monononitrate, soliphenacin, potassium iodide, Ambroxol for medical use by prescriptions for drugs to provide certain categories of citizens entitled to preferential drug provision, in accordance with the Federal Law of 07/17/1999 No. 178-ะคะ on state social assistance in 2025
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINthe Drug Isosorbide Monononitrate, Soliphenacin, Potassium Iodide, Ambroxol for Medical Use by Prescription for Drugs to Ensure about ... - Russia Tender
The THE MINISTRY OF HEALTH OF THE ULYANOVSK REGION, a Government sector organization in Russia, has announced a new tender for the Drug Isosorbide Monononitrate, Soliphenacin, Potassium Iodide, Ambroxol for Medical Use by Prescription for Drugs to Ensure about .... This tender is published on RussiaTenders under RUT Ref No: 127632889 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-10.
The estimated tender value is 215846.40, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
